Authors:
BRACKMANN HH
EGBRING R
FERSTER A
FONDU P
GIRARDEL JM
KREUZ W
MASURE R
MILOSZEWSKI K
STIBBE J
ZIMMERMANN R
HOOS A
Citation: Hh. Brackmann et al., PHARMACOKINETICS AND TOLERABILITY OF FACTOR-XIII CONCENTRATES PREPARED FROM HUMAN PLACENTA OR PLASMA - A CROSSOVER RANDOMIZED STUDY, Thrombosis and haemostasis, 74(2), 1995, pp. 622-625
Authors:
LENZ E
KLARMANN D
BECKER S
ESCURIOLA C
MARTINEZ I
KREUZ W
Citation: E. Lenz et al., LOW-MOLECULAR-WEIGHT-HEPARIN FOR SECONDARY PROPHYLAXIS OF THROMBOSIS IN PEDIATRIC-PATIENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 981-981
Authors:
AUERSWALD G
KREUZ W
AUBERGER K
DEINHARDT M
ROTH U
Citation: G. Auerswald et al., CONTINUOUS-INFUSION OF FACTOR-VIII AFTER ELECTIVE SURGERY IN CHILDRENWITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1024-1024
Authors:
EHRENFORTH S
MONDORF W
SIEGERT S
KREUZ W
SCHARRER I
Citation: S. Ehrenforth et al., COMPARATIVE-EVALUATION OF ANTI-HUMAN AND ANTI-PORCINE-F-VIII INHIBITOR LEVELS IN HEMOPHILIACS AND NON-HEMOPHILIC PATIENTS, Thrombosis and haemostasis, 73(6), 1995, pp. 1027-1027
Authors:
DZINAJ T
SCHMIDT H
MARTINEZ I
LENZ E
ESCURIOLA C
BECKER S
FUNK M
KLARMANN D
GUNGOR T
KREUZ W
Citation: T. Dzinaj et al., THE MANIFESTATION OF ARTHROPATHY IN HEMOPHILIACS UNDERGOING DIFFERENTTHERAPY REGIMES, Thrombosis and haemostasis, 73(6), 1995, pp. 1036-1036
Authors:
MENTZER D
BECKER S
DOHRING N
JOSEPHSTEINER J
VIGH T
JACOBI G
SCHARRER I
KREUZ W
Citation: D. Mentzer et al., HISTORY OF BLEEDINGS CORRELATED WITH LABORATORY FINDINGS IN PATIENTS WITH VALPROATE-INDUCED AND CONGENITAL VON-WILLEBRANDS DISEASE, Thrombosis and haemostasis, 73(6), 1995, pp. 1174-1174
Authors:
MARTINEZSAGUER I
ESCURIOLAETTINGSHAUSEN C
BEEG T
BECKER S
LENZ E
SCHARRER I
KREUZ W
Citation: I. Martinezsaguer et al., FOLLICULAR BLEEDING - AN UNUSUAL BLEEDING-EMERGENCY IN A YOUNG WOMAN WITH VWD TYPE-III, Thrombosis and haemostasis, 73(6), 1995, pp. 1175-1175
Citation: W. Kreuz et T. Beeg, A NEW KIND OF PROTEIN-C-DEFICIENCY IN NEONATES INTERMITTENT TREATMENTWITH PROTEIN-C-CONCENTRATE OF HEREDITARY TEMPORARY NEONATAL PROTEIN-C-DEFICIENCY, Thrombosis and haemostasis, 73(6), 1995, pp. 1293-1293
Citation: T. Beeg et al., PROTEIN-C SUBSTITUTION-THERAPY WITH A MONOCLONAL PURIFIED PROTEIN-C-CONCENTRATE IN NEWBORNS SUFFERING FROM PURPURA FULMINANS, Thrombosis and haemostasis, 73(6), 1995, pp. 1294-1294
Authors:
JOSEPHSTEINER J
KLARMANN D
MENTZER D
BEEG T
KREUZ W
Citation: J. Josephsteiner et al., TREATMENT OF PATIENTS WITH HEREDITARY ANGIONEUROTIC-EDEMA WITH A VIRUS-INACTIVATED C1-INHIBITOR CONCENTRATE, Thrombosis and haemostasis, 73(6), 1995, pp. 1409-1409
Authors:
BECKER S
MARTINEZSAGUER I
LENZ E
ESCURIOLAETTINGSHAUSEN C
SCHARRER I
DINGELDEIN E
KREUZ W
Citation: S. Becker et al., VARIOUS APTT AND F-XII-ASSAYS IN A FAMILY WITH HETEROZYGOUS F-XII-DEFICIENCY, Thrombosis and haemostasis, 73(6), 1995, pp. 1442-1442
Authors:
KLAMANN D
KREUZ W
LENZ E
RABENAU H
DOERR HW
KORNHUBER B
Citation: D. Klamann et al., LOW-PREVALENCE OF HEPATITIS-E ANTIBODIES IN HEPATITIS-C POSITIVE PATIENTS WITH CONGENITAL COAGULATION DISORDERS, Thrombosis and haemostasis, 73(6), 1995, pp. 1459-1459
Authors:
KLARMANN D
KREUZ W
AUBERGER K
AUERSWALD G
STOHR S
LENZ E
RABENAU H
GANDENBERGER S
ROTH W
GOETHE JW
Citation: D. Klarmann et al., LOW-RISK OF INTRAFAMILIAL HEPATITIS-C TRANSMISSION IN HEPATITIS-C POSITIVE CHILDREN WITH COAGULATION DISORDERS, Thrombosis and haemostasis, 73(6), 1995, pp. 1459-1459
Authors:
DREYFUS M
MASTERSON M
DAVID M
RIVARD GE
MULLER FM
KREUZ W
BEEG T
MINFORD A
ALLGROVE J
BERGMANN F
MITCHELL VE
HAWORTH C
NELSON K
SCHWARZ HP
Citation: M. Dreyfus et al., REPLACEMENT THERAPY WITH A MONOCLONAL-ANTIBODY PURIFIED PROTEIN-C CONCENTRATE IN NEWBORNS WITH SEVERE CONGENITAL PROTEIN-C DEFICIENCY, Seminars in thrombosis and hemostasis, 21(4), 1995, pp. 371-381
Authors:
KREUZ W
BECKER S
LENZ E
MARTINEZSAGUER I
ESCURIOLAETTINGSHAUSEN C
FUNK M
EHRENFORTH S
AUERSWALD G
KORNHUBER B
Citation: W. Kreuz et al., FACTOR-VIII INHIBITORS IN PATIENTS WITH HEMOPHILIA-A - EPIDEMIOLOGY OF INHIBITOR DEVELOPMENT AND INDUCTION OF IMMUNE TOLERANCE FOR FACTOR-VIII, Seminars in thrombosis and hemostasis, 21(4), 1995, pp. 382-389
Citation: D. Klarmann et al., LOW-PREVALENCE OF HEPATITIS-E VIRUS-ANTIBODIES IN HEPATITIS-C VIRUS-POSITIVE PATIENTS WITH COAGULATION DISORDERS, Transfusion, 35(11), 1995, pp. 969-970
Authors:
KREUZ W
SALMUN L
BORTE M
BRINKMAN H
BRAY GL
GOMPERTS E
Citation: W. Kreuz et al., SAFETY OF A SOLVENT-DETERGENT TREATED INTRAVENOUS IMMUNOGLOBULIN (GAMMAGARD(TM) S D) IN PREVIOUSLY UN-INFUSED PATIENTS/, Blood, 86(10), 1995, pp. 3419-3419
Authors:
AUERSWALD G
AUBERGER K
KREUZ W
DEINHARD M
ROTH U
Citation: G. Auerswald et al., CONTINOUS INFUSION OF FACTOR-VII AFTER ELECTIVE SURGERY IN CHILDREN WITH HEMOPHILIA-A AND VON-WILLEBRAND DISEASE, Blood, 86(10), 1995, pp. 3445-3445